-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
- Home
- About
- Media centre
- Bell en Gong Archief
- 10-jarige beursnotering Fagron
10-jarige beursnotering Fagron
05/10/2017
Fagron viert 10-jarige beursnotering met opening beurshandel
Fagron N.V. (ticker symbool: FAGR) viert haar 10-jarige beursnotering met een slag op de gong door CEO Hans Stols.
Fagron is sinds 5 oktober 2007 genoteerd aan Euronext Amsterdam en Euronext Brussel. Met de afronding van de verkoop van de dentale en medische divisies in 2014 en de verkoop van de software divisie in 2015 is Fagron getransformeerd tot een toonaangevende onderneming actief in farmaceutische bereidingen.
Fagron richt zich op het leveren van gepersonaliseerde zorg aan ziekenhuizen, apotheken, klinieken en patiënten in haar kernmarkten Europa, Noord Amerika en Zuid Amerika.
Voor meer informatie: www.fagron.nl